Kimberly-Clark Corporation (KMB)
| Market Cap | 32.77B -20.3% |
| Revenue (ttm) | 16.58B +0.7% |
| Net Income | 1.96B -19.5% |
| EPS | 5.86 -19.4% |
| Shares Out | 332.58M |
| PE Ratio | 16.83 |
| Forward PE | 14.06 |
| Dividend | $5.12 (5.19%) |
| Ex-Dividend Date | Sep 4, 2026 |
| Volume | 1,440,528 |
| Open | 98.00 |
| Previous Close | 98.43 |
| Day's Range | 97.34 - 99.01 |
| 52-Week Range | 92.42 - 125.32 |
| Beta | 0.27 |
| Analysts | Buy |
| Price Target | 116.33 (+18.05%) |
| Est. Earnings | Oct 29, 2026 |
About KMB
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. It operates in two segments, North America and International Personal Care. The North America segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, facial and bathroom tissue, paper towels, napkins, wipers, tissue, towels, soaps and sanitizers, and other related products under the Huggies, Pull-Ups, Goodnites, Kotex, Poise, Dep... [Read more]
Financial Performance
In 2025, Kimberly-Clark's revenue was $16.45 billion, a decrease of -2.13% compared to the previous year's $16.81 billion. Earnings were $2.02 billion, a decrease of -20.59%.
Financial StatementsAnalyst Summary
According to 16 analysts, the average rating for KMB stock is "Buy." The 12-month stock price target is $116.33, which is an increase of 18.05% from the latest price.
News
Burning a Hole in My Pocket
I'm talking about the cash I have sitting here that I desperately want to get into the market. Earlier this year, I got a chunk of money from selling a house.
Kimberly-Clark offers remedies in bid for EU approval of Kenvue deal
Kimberly-Clark has offered concessions to address EU antitrust concerns about its $40 billion bid for Tylenol maker Kenvue , a filing on the European Commission website showed on Wednesday.
Kimberly-Clark readies EU remedies in bid for Kenvue deal, sources say
Kimberly-Clark is readying concessions to address EU antitrust concerns about its bid for Tylenol maker Kenvue that could help it win approval for the $40 billion deal after a preliminary review,...
My Favorite Consumer Staples Play Right Now
Owning consumer staples stocks is an absolute must in a dividend investing strategy. Most people turn to dividend stocks for two reasons — to generate income or to put the magic of compounding to work...
Kimberly-Clark Transcript: Barclays 19th Annual Global Consumer Conference
Powering Care strategy has driven consistent growth, margin expansion, and reduced volatility, with premiumization and innovation as key levers. Despite near-term headwinds from China, logistics, and cost inflation, long-term growth and synergy opportunities from the Kenvue acquisition and the Suzano JV remain robust.
Huggies® Rallies Communities to Recognize the Fighting Spirit of NICU Babies During NICU Awareness Month
Huggies renames its nano and micro preemie diapers "Huggies Little Fighters" and marks NICU Awareness Month by spotlighting real stories and supporting families CHICAGO, Sept. 3, 2026 /PRNewswire/ -- ...
Australia clears Kimberly-Clark's acquisition of Kenvue but requires Carefree, Stayfree divestment
Australia's competition regulator on Wednesday approved Kimberly-Clark's proposed $40 billion takeover of Kenvue , on condition the company divests Kenvue's Carefree and Stayfree period care brands ...
Kimberly-Clark to Webcast its Presentation at Barclays 19th Annual Global Consumer Staples Conference
DALLAS, Sept. 1, 2026 /PRNewswire/ -- Mike Hsu, Chairman and CEO of Kimberly-Clark Corporation (NASDAQ: KMB), Russ Torres, President and Chief Operating Officer, and Nelson Urdaneta, Chief Financial O...
Kimberly-Clark seeks EU approval for $40 billion Kenvue deal
Kimberly-Clark has asked EU regulators permission for its proposed $40 billion takeover of Tylenol maker Kenvue, documents on the EU Commission's website showed.
The AI productivity payoff is coming. Here are 20 stocks primed to capture the gains as adoption spreads.
So far investors have been focused on artificial-intelligence infrastructure plays rather than productivity beneficiaries, says Goldman Sachs.
Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel
Accomplished legal executive and global litigator brings proven track record of enterprise risk management and strategic leadership to support Kimberly-Clark's next chapter of growth DALLAS, Aug. 13, ...
Kimberly-Clark Earnings Call Transcript: Q2 2026
Q2 saw solid execution and productivity gains, offsetting headwinds from China disruption and North America inventory reductions. Adjusted operating profit and EPS exceeded expectations, aided by a tariff refund, while innovation and integration initiatives advanced. Guidance reflects ongoing input cost and China-related challenges.
Kimberly-Clark Earnings release: Q2 2026
Kimberly-Clark released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
Kimberly-Clark Slides: Q2 2026
Kimberly-Clark has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 4, 2026.
Kimberly-Clark Quarterly report: Q2 2026
Kimberly-Clark has published its Q2 2026 quarterly earnings report on August 4, 2026.
Huggies Stumble in China After Social-Media Firestorm
A state-run newspaper said the diapers tested positive for a substance called formamide. Huggies maker Kimberly-Clark said the findings are false.
Kimberly-Clark Reports Lower Profit After China Social Media Disruption
Kimberly-Clark reported lower profit in its second quarter and revenue missed estimates, as allegations about the quality of diapers in the China market disrupted sales.
Kimberly-Clark cuts annual forecasts as China disruption weighs on diaper sales
Kimberly-Clark cut its annual sales and profit forecasts on Tuesday, citing a significant hit to second-quarter sales in China that stemmed from false claims about the quality of some of its diaper b...
Kimberly-Clark Announces Second Quarter and First Half 2026 Results, Updates 2026 Outlook
Makes significant strides in strategic transformation while sustaining strong business momentum DALLAS, Aug. 4, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (Nasdaq: KMB) today reported second quar...
Kimberly-Clark Earnings Call Transcript: Q2 2026
Q2 results showed resilient performance amid headwinds, with flat organic sales and strong productivity gains. Share gains in key international markets offset North America softness, but China disruption led to a lowered full-year outlook. Integration of Arbex and Kenvue advances.
Kimberly-Clark Earnings release: Q2 2026
Kimberly-Clark released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
Kimberly-Clark Slides: Q2 2026
Kimberly-Clark has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 4, 2026.
Kimberly-Clark Quarterly report: Q2 2026
Kimberly-Clark has published its Q2 2026 quarterly earnings report on August 4, 2026.
Kimberly-Clark Declares Quarterly Dividend
DALLAS, Aug. 3, 2026 /PRNewswire/ -- The board of directors of Kimberly-Clark Corporation (NASDAQ: KMB) has declared a regular quarterly dividend of $1.28 per share. The dividend is payable in cash on...
KIMBERLY-CLARK UNVEILS PROPRIETARY ALTERNATIVE NATURAL FIBER INNOVATION PROGRAM TO ADVANCE ITS "BETTER CARE FOR A BETTER WORLD" COMMITMENT
Company Pioneers Next-Generation, Agriculture-Based Materials Platform to Reshape How It Manufactures Hygiene Products DALLAS, Aug. 3, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) tod...